• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

紫杉醇涂层球囊导管治疗冠状动脉支架内再狭窄时无复流现象。

No-reflow phenomenon during treatment of coronary in-stent restenosis with a Paclitaxel-coated balloon catheter.

机构信息

Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea.

出版信息

Korean Circ J. 2012 Jun;42(6):431-3. doi: 10.4070/kcj.2012.42.6.431. Epub 2012 Jun 28.

DOI:10.4070/kcj.2012.42.6.431
PMID:22787476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3390431/
Abstract

Drug-eluting balloon (DEB) with angioplasty a paclitaxel-coated balloon catheter is an effective treatment option in patients with in-stent restenosis (ISR) after a drug-eluting stent (DES). We describe a case in which 'no-reflow' phenomenon developed after DEB angioplasty of a DES ISR lesion. Coronary flow was restored after intracoronary administration of nicorandil.

摘要

药物洗脱球囊（DEB）联合经皮腔内冠状动脉成形术紫杉醇涂层球囊导管是药物洗脱支架（DES）后支架内再狭窄（ISR）患者的有效治疗选择。我们描述了一例 DEB 血管成形术治疗 DES ISR 病变后出现“无复流”现象的病例。冠状动脉内给予硝酸异山梨酯后恢复了冠状动脉血流。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa47/3390431/9e1be9647233/kcj-42-431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa47/3390431/53d548717e61/kcj-42-431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa47/3390431/9e1be9647233/kcj-42-431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa47/3390431/53d548717e61/kcj-42-431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa47/3390431/9e1be9647233/kcj-42-431-g002.jpg

相似文献

1
No-reflow phenomenon during treatment of coronary in-stent restenosis with a Paclitaxel-coated balloon catheter.紫杉醇涂层球囊导管治疗冠状动脉支架内再狭窄时无复流现象。
Korean Circ J. 2012 Jun;42(6):431-3. doi: 10.4070/kcj.2012.42.6.431. Epub 2012 Jun 28.
2
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果：PEPCAD-DES 研究的见解（使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄）。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
3
A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.紫杉醇洗脱球囊与依维莫司洗脱支架治疗任何部位支架内再狭窄的随机比较：DARE 试验。
JACC Cardiovasc Interv. 2018 Feb 12;11(3):275-283. doi: 10.1016/j.jcin.2017.10.024. Epub 2017 Nov 7.
4
A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.紫杉醇涂层球囊与紫杉醇洗脱支架治疗药物洗脱支架内再狭窄的前瞻性、多中心、随机试验：来自 PEPCAD China ISR 试验的结果。
JACC Cardiovasc Interv. 2014 Feb;7(2):204-211. doi: 10.1016/j.jcin.2013.08.011.
5
Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.紫杉醇涂层球囊血管成形术后晚期再狭窄发生于药物洗脱支架再狭窄患者中。
J Am Coll Cardiol. 2015 Jul 7;66(1):14-22. doi: 10.1016/j.jacc.2015.05.002.
6
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis.药物涂层球囊血管成形术治疗支架内再狭窄中优化操作相关因素的影响。
JACC Cardiovasc Interv. 2018 May 28;11(10):969-978. doi: 10.1016/j.jcin.2018.02.002.
7
Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.药物涂层球囊与球囊血管成形术治疗后药物洗脱支架再狭窄的血管造影模式：PEPCAD-DES研究的晚期管腔丢失亚组分析
Catheter Cardiovasc Interv. 2016 Oct;88(4):529-534. doi: 10.1002/ccd.26451. Epub 2016 Feb 19.
8
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.药物涂层球囊血管成形术与药物洗脱支架置入术治疗冠状动脉支架再狭窄患者的比较。
J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006.
9
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.紫杉醇涂层球囊导管与常规球囊血管成形术治疗金属裸支架再狭窄和药物洗脱支架再狭窄患者的多中心随机比较。
Am Heart J. 2013 Sep;166(3):527-33. doi: 10.1016/j.ahj.2013.07.002. Epub 2013 Aug 13.
10
Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.药物洗脱球囊、药物洗脱支架与普通球囊血管成形术治疗支架内再狭窄的比较：11 项随机对照试验的网络荟萃分析。
JACC Cardiovasc Interv. 2015 Mar;8(3):382-394. doi: 10.1016/j.jcin.2014.09.023. Epub 2015 Feb 18.

本文引用的文献

1
Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model.紫杉醇涂层球囊后扩张后猪冠状动脉支架模型的血管舒缩功能。
JACC Cardiovasc Interv. 2011 Feb;4(2):247-55. doi: 10.1016/j.jcin.2010.08.028.
2
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.紫杉醇涂层球囊导管治疗小冠状动脉。
Clin Res Cardiol. 2010 Mar;99(3):165-74. doi: 10.1007/s00392-009-0101-6. Epub 2010 Jan 6.
3
Myocardial no-reflow in humans.人类心肌无复流现象
J Am Coll Cardiol. 2009 Jul 21;54(4):281-92. doi: 10.1016/j.jacc.2009.03.054.
4
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄的比较。
Circulation. 2009 Jun 16;119(23):2986-94. doi: 10.1161/CIRCULATIONAHA.108.839282. Epub 2009 Jun 1.
5
Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis.尼可地尔治疗急性心肌梗死患者：一项荟萃分析。
Circ J. 2009 May;73(5):925-31. doi: 10.1253/circj.cj-08-1059. Epub 2009 Mar 27.
6
Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.冠状动脉无复流现象：从实验研究室到心导管检查室
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):950-7. doi: 10.1002/ccd.21715.
7
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.使用紫杉醇涂层球囊导管治疗冠状动脉支架内再狭窄。
N Engl J Med. 2006 Nov 16;355(20):2113-24. doi: 10.1056/NEJMoa061254. Epub 2006 Nov 13.
8
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.紫杉醇球囊涂层，一种预防和治疗再狭窄的新方法。
Circulation. 2004 Aug 17;110(7):810-4. doi: 10.1161/01.CIR.0000138929.71660.E0. Epub 2004 Aug 9.
9
Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.冠状动脉内给予尼可地尔对预防旋磨术期间无复流/慢血流现象的作用。
Circ J. 2002 Dec;66(12):1119-23. doi: 10.1253/circj.66.1119.
10
The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media.冠状动脉疾病对冠状动脉对非离子型造影剂血管舒缩反应的影响。
Circulation. 2000 Feb 8;101(5):491-7. doi: 10.1161/01.cir.101.5.491.